Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|December 16, 2024
Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case reportChiara Bernardi, Yan Beauverd, Thien An Tran, et al.
Bone Marrow Research|April 16, 2015
Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic MalignanciesSandra Paiano, Eddy Roosnek, Yordanka Tirefort, et al.
Annals of Hematology|October 24, 2020
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialClaire Seydoux, Michael Medinger, Sabine Gerull, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
Open Forum Infectious Diseases|January 7, 2022
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?Romain Samuel Roth, Stavroula Masouridi-Levrat, Yves Chalandon, et al.
Viruses|April 28, 2023
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients PlasmaMarie-Céline Zanella, Diem-Lan Vu, Krisztina Hosszu-Fellous, et al.
Cytotherapy|December 6, 2011
Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashionSandrine Meyer-Monard, André Tichelli, Carolyn Troeger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletionYan Beauverd, Eddy Roosnek, Yordanka Tirefort, et al.
Blood|September 22, 2005
Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complicationsYves Chalandon, Sylvie Degermann, Jean Villard, et al.
Ejhaem|February 23, 2023
Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is betterEkaterina Rebmann, Mitja Nabergoj, Bastien Grandjean, et al.
Pageof 22